Clearwater Paper Corp. 2025 Annual Report (10-K) Summary
Business Context and Reporting Period
This Form 10-K covers the fiscal year ended December 31, 2025. Clearwater Paper Corporation is a leading manufacturer of Solid Bleached Sulfate (SBS) paperboard packaging products in North America. The reporting period reflects a strategic pivot following the divestiture of its tissue business in November 2024 and the acquisition of the Augusta, Georgia paperboard facility in May 2024. The company now operates as a single-segment business focused exclusively on paperboard packaging.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Net Sales | $1,555.4 million | $1,383.6 million | +12% |
| Gross Profit | $115.6 million | $76.1 million | +52% |
| Gross Margin | 7.4% | 5.5% | +190 bps |
| Net Income (Loss) | $(18.6) million | $196.3 million | Significant Decline |
| Income from Continuing Ops | $(53.0) million | $(74.0) million | Improvement |
| Adjusted EBITDA (Continuing Ops) | $107.2 million | $36.0 million | +198% |
| Operating Cash Flow | $12.3 million | $61.4 million | -80% |
| Total Debt | $347.4 million | $284.1 million | +22% |
| Cash & Equivalents | $30.7 million | $79.6 million | -61% |
Note: 2024 Net Income included a $307.2 million gain on the sale of discontinued operations (tissue business). 2025 Net Loss includes a $48.0 million goodwill impairment charge.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 12% primarily due to the inclusion of the Augusta facility operations, offset by lower market prices and product mix changes.
- Goodwill Impairment: The company recorded a non-cash goodwill impairment charge of $48.0 million in Q3 2025, driven by a sustained decline in market capitalization and paperboard market softness. This resulted in a full impairment of goodwill.
- Cost Structure: Cost of sales increased 10% due to higher volumes from the Augusta acquisition, partially offset by cost reduction initiatives. Input costs rose due to energy and chemical prices, while fiber costs decreased on a per-ton basis.
- Insurance Recovery: The company received a partial settlement of $23.0 million related to representation and warranty insurance claims from the Augusta acquisition.
- Discontinued Operations: The tissue business was fully divested in late 2024; 2025 results reflect only continuing operations.
Guidance, Outlook, and Risks
2026 Outlook:
- Revenue: Expected to range between $1.45 billion and $1.55 billion. Higher volumes are expected to be offset by lower carry-over pricing from 2025.
- Costs: Input cost inflation is estimated at 2-3%, expected to be offset by productivity initiatives. Major maintenance outages are projected to cost approximately $50 million.
- Working Capital: Targeting $20 million in improvements, primarily through finished goods inventory reduction.
- Recent Disruptions: Severe weather in early 2026 impacted Augusta and Cypress Bend facilities, resulting in an estimated $20 million reduction in Adjusted EBITDA for the year.
Key Risks and Contingencies:
- Debt Covenants: The company's fixed charge coverage ratio was approximately 0.6x as of Dec 31, 2025, which is below the 1.1x threshold required if availability under the ABL Credit Agreement falls below specific levels. Management expects to remain in compliance based on current projections.
- Market Conditions: Increased supply in the North American paperboard market and competitive pricing pressures continue to impact margins.
- Legal Proceedings: The company is a defendant in PFAS-related litigation involving the Augusta facility. Management believes it has meritorious defenses.
- Labor: A collective bargaining agreement at the Lewiston, Idaho facility expired in Q3 2025; negotiations are ongoing.
Investor Verification Checklist
- Debt Covenant Compliance: Verify the company's ability to maintain the required fixed charge coverage ratio given the current 0.6x level and potential market volatility.
- Goodwill Impairment: Assess the impact of the full goodwill impairment on future earnings and the sustainability of the current market valuation.
- 2026 Weather Impact: Monitor the extent of the $20 million Adjusted EBITDA reduction cited for early 2026 weather disruptions and its effect on full-year guidance.
- Insurance Claims: Track the status of remaining representation and warranty insurance claims from the Augusta acquisition beyond the $23 million partial settlement.
- Working Capital Management: Evaluate the execution of the $20 million working capital improvement plan and its potential negative impact on fixed cost absorption.